← Eichor
Condition: Vaccine Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Vaccine

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts
Phase 2 · 1 location(s) · Zagazig University · NCT05291845A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Phase 3 · 174 location(s) · Pfizer · NCT07282665Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure
NA · 1 location(s) · Centre Hospitalier Universitaire de Nice · NCT06907667Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
Phase 2 · 2 location(s) · University of Maryland, Baltimore · NCT06624839Covid-19 and Influenza Oral Vaccine Study
Phase 1 · 1 location(s) · Vaxine Pty Ltd · NCT06355232Prospective Study for the FOLLOW-UP of Human Monkeypox Cases and Smallpox Vaccinees at Risk
Phase N/A · 1 location(s) · Institute of Tropical Medicine, Belgium · NCT05879965Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COV
Phase 1 · 1 location(s) · The Methodist Hospital Research Institute · NCT06821100Dengue Vaccine Strategy in Children Aged 9 to 17 Years in the French Caribbean
Phase N/A · 1 location(s) · University Hospital Center of Martinique · NCT04839757Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs
Phase 4 · 1 location(s) · University of Sao Paulo General Hospital · NCT07242092A Study Evaluating the Safety and Immunogenicity of MVA Strain Monkeypox Attenuated Live Vaccine
Phase 1 · 1 location(s) · Shanghai Institute Of Biological Products · NCT06771479Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer
Phase 1 · 1 location(s) · Sichuan University · NCT06344156Autologous Dendritic Cell Vaccine For Recurrent Respiratory Papillomatosis (RRP) Patients
Phase 1 · 1 location(s) · Mayo Clinic · NCT07317154A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to Prevent Lyme Disease in Healthy Parti
Phase 2 · 8 location(s) · ModernaTX, Inc. · NCT07561294Clinical Efficacy of Tumour Treatment Vaccine (TTV) Combined With PD-1 in the Treatment of Relapsed Refractory Advanced
NA · 1 location(s) · Wuxi People's Hospital · NCT06430502Clinical Trials of Quadrivalent Influenza Vaccine
Phase 1/Phase 2 · 1 location(s) · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · NCT06824519PhaseⅡClinical Trial of Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells)
Phase 2 · 1 location(s) · Sinovac Life Sciences Co., Ltd. · NCT06967272Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine
Phase 3 · 1 location(s) · Sinovac Life Sciences Co., Ltd. · NCT06617715Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected
Phase 1/Phase 2 · 6 location(s) · Everest Medicines (Beijing) Co., Ltd. · NCT07095868Antibiotics and Vaccine Immune Responses Study
Phase 4 · 1 location(s) · South Australian Health and Medical Research Institute · NCT06148025A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid Tumor
NA · 1 location(s) · Fudan University · NCT06682117A Trial of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine, Administered to Healthy Adults Living Without and W
Phase 1 · 3 location(s) · International AIDS Vaccine Initiative · NCT06617091Cholera Control by Case-area Targeted Interventions (CATIs)
NA · 1 location(s) · International Centre for Diarrhoeal Disease Research, Bangla · NCT07685574Butantan-DV Vaccine in Elderly Populations (DEN-04-IB)
Phase 3 · 5 location(s) · Butantan Institute · NCT06891950Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
Phase N/A · 1 location(s) · University of Oxford · NCT05571735NGS-MRD Assessment of Combination Immunotherapies Targeting B-ALL
Phase 1 · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT05262673A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
Phase 4 · 6 location(s) · ModernaTX, Inc. · NCT06585241Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine
Phase 1/Phase 2 · 7 location(s) · Aramis Biotechnologies Inc. · NCT07291635Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After H
Phase 2 · 3 location(s) · Universiteit Antwerpen · NCT07407569Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-1)
Phase 3 · 41 location(s) · Merck Sharp & Dohme LLC · NCT07013487
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.